9HZ-20300-90582 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-08
Dose 1 — Pfizer-BioNTech
2021-04-15
Dose 2 — Pfizer-BioNTech
2021-10-22
Dose 3 — Pfizer-BioNTech
2021-10-24
Registered in v-safe
2021-10-24
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Redness, Itching · Muscle or body aches

Adult check-in
2021-10-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-27
Survey response — days 1–6 daily, dose 3
MedDRA: Dry eye, Dry throat — Feeling: Fair · Fatigue or tiredness

Free text: Dry eyes, dry throat

MedDRA releases: 2024-11 · check-in free text available
2021-10-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-08	Pfizer-BioNTech	No
2	2021-04-15	Pfizer-BioNTech	No
3	2021-10-22	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-27

Systemic reaction (other): Dry eyes, dry throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dry eye	·	·	✓
SRO	Dry throat	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release